Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06194539 · ClinicalTrials.gov registry record

Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)

A clinical trial of Fertility Issues, sponsored by Bar-Chama, Natan, M.D..

Recruiting
Registry status
75
Enrollment target
1
Study location

NCT06194539 is a study of Fertility Issues that is actively recruiting participants, run by Bar-Chama, Natan, M.D.. The registered enrollment target is 75 participants, below the 156-participant average among 4 other Fertility Issues trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06194539, a study of Fertility Issues, is actively recruiting participants, sponsored by Bar-Chama, Natan, M.D..

RECRUITING
Registry status
75 participants
Enrollment target
1
Study location

Study Summary

This study will aim to assess the fertility status of men with Spinal Muscular Atrophy (SMA) not on disease-modifying therapies. Participants will: 1. Complete online questionnaires that will assess SMA diagnosis and disease burden, medical and surgical history, medication usage, and fertility status and perspectives. 2. Over the 3-month initial study baseline period participants will provide two separate ejaculates for semen analysis and a single determination of sperm quality using DNA fragmentation testing using home collection and subsequent shipment to a central laboratory. 3. Over the initial study baseline period of 3 months study participants will obtain a blood test to determine male reproductive hormone levels. During the 24-month study duration, participants will be requested to undergo a yearly semen analysis and complete online relevant questionnaires.

Conditions Studied

Study Locations (1)

New Jersey

  • Natan Bar-Chama MD - Cresskill

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2024-02
Est. Completion 2026-07

Sponsor

Bar-Chama, Natan, M.D.

1 total trials

What the Registry Record Tells You About NCT06194539

The ClinicalTrials.gov registry entry for NCT06194539 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 156-participant average among 4 other Fertility Issues trials with a reported enrollment target (52% lower). The listed sponsor is Bar-Chama, Natan, M.D., which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fertility Issues appearing as the primary indexed condition, and to 0 interventions.

NCT06194539 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT06194539 about?

NCT06194539 is a clinical study titled "Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)". This study will aim to assess the fertility status of men with Spinal Muscular Atrophy (SMA) not on disease-modifying therapies. Participants will: 1. Complete online questionnaires that will assess SMA diagnosis and disease burden, medical and surgical history, medication usage, and fertility sta...

What is the current status of trial NCT06194539?

This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2024-02. Estimated completion is 2026-07.

What conditions does trial NCT06194539 study?

This clinical trial studies the following conditions: Fertility Issues.

Who is sponsoring clinical trial NCT06194539?

This trial is sponsored by Bar-Chama, Natan, M.D., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06194539 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fertility Issues

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.